Ultrasound for Acute Chest Syndrome
(POCUS Trial)

Recruiting in Palo Alto (17 mi)

Overseen bySeethal Jacob, MD

Age: < 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Indiana University

No Placebo Group

Trial Summary

What is the purpose of this trial?Feasibility and reliability of ultrasound in the inpatient hematology setting.

Eligibility Criteria

This clinical trial is open to individuals who have been diagnosed with conditions such as Acute Coronary Syndrome or Sickle Cell Disease, specifically those experiencing Acute Chest Syndrome. The study seems to focus on patients in a hospital setting under the care of a hematology team.

Inclusion Criteria

I have been diagnosed with sickle cell disease.

I was hospitalized for a sickle cell disease complication.

I am 25 years old or younger.

Exclusion Criteria

Patient is considered hemodynamically unstable to undergo consent and study procedures

POCUS operator not available

I was diagnosed with acute coronary syndrome before being admitted.

Participant Groups

The trial is testing the feasibility and reliability of using point-of-care ultrasound for patients with certain cardiovascular and blood disorders while they are admitted to the hospital.

1Treatment groups

Experimental Treatment

Group I: UltrasoundExperimental Treatment1 Intervention

Ultrasound days 1, 3, and 5 of hospitalization